CellFinder is a freely available on-line resource for cell-based data in mammalian cells and in vitro cell lines. CellFinder was developed to provide easier access to different types of cell-based data, which include anatomical and microscopic images, protein expression and whole genome mRNA expression profiles. In this short communication, we describe the collection, processing and storage of gene expression data for the CellFinder resource. Studies involving the use of normal cells and/or production of pluripotent stem cells or their engineered cell types, were chosen from public data repositories of mRNA expression data. Samples in each study were manually curated with ontology terms, and the data was further processed to yield normalized expression data. Sample, experiment and molecular data were stored in a postgreSQL database. The resulting molecular database currently contains 1588 samples from 56 studies, covering 42 cell types in human and mouse. The molecular database is undergoing continuous development and will serve as a source of standardized, processed and expertly annotated data for CellFinder analysis tools such as MarkerTool and CompareTool.
INTRODUCTION
The CellFinder data repository was initiated in 2004 [1] as comprehensive resource for data used to characterize mammalian cells in tissues over different developmental stages (www.cellfinder.org). CellFinder uses the collated ontology framework of CELDA [2] to delineate relationships between terms associated with cells and cell lines. These links allow users to explore cells through spatial and developmental contexts in the CellFinder resource using the Body Browser [3] and developmental tree functions in CellFinder. Furthermore, we are developing tools for the CellFinder platform to analyze molecular data, such as CompareTool and MarkerTool [4] .
Ten years ago, it was revealed that somatic cells could be reprogrammed to induced pluripotent stem cells (iPSCs) [5] , which have the ability to differentiate into cells of all three germ layers. This development has revolutionized the field of regenerative medicine by circumventing ethical issues surrounding the procurement of embryonic stem cells and providing a renewable source of pluripotent, patient-specific cells. iPS cells can now be routinely generated from a variety of tissues, including skin fibroblasts, blood and urinary cells. Upon differentiating the iPS cells into specific cell types, such as neurons or cardiomyocytes, these engineered cells may find applications in individualized drug testing, disease modeling and cell replacement therapy. The CellFinder resource will provide a solid basis to which the engineered cell types can be compared to their native counterparts.
The importance of a cell-based resource is becoming more apparent with the development of new technologies that enable high-throughput analysis, such as next-generation sequencing, mass spectrometry and high-content screening. These new technologies generate vast amounts of data, which could be stored in public databases or in supplementary files as part of a publication. Locating specific information about a cell is confounded by the lack of standardized annotation of the samples that have been subject to high-throughput analysis. To facilitate querying of cell-based data, we are manually annotating a selection of microarray datasets with ontology terms from the CellFinder resource. The present study describes the development of a molecular database of mRNA transcription data to be used as the data source for the CellFinder tools.
METHODS

Data wrangling
Microarray studies were selected from public repositories such as Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) and ArrayExpress (https://www.ebi.ac.uk/arrayexpress).
We selected studies of interest to our laboratory, which included studies involving: 1) reprogramming to iPS; 2) the derivation of specific cell types from iPS; 3) kidney disease and controls; 4) healthy or normal control tissues as a baseline for gene expression in normal tissues.
All samples were manually annotated to ontology terms from CellFinder.
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Cell Type Human Mouse
ESC 126 0 iPS 218 0 other PSC 10 0 kidney 582 49 urethra 10 6 brain 205 0 brain(engineered) 31 0 skin 68 0 skin(engineered) 3 0 liver 40 0 liver (engineered) 27 0 other tissues 213 0
Data processing and storage
Following annotation of each sample for which microarray data was available, the raw microarray data was downloaded from public databases, and normalized for within-study datasets (using BioC packages "affy" [6] and "lumi" [7] for Affymetrix and Illumina arrays, respectively, in R version 3.1 or greater [8] ) and normalized with YuGene [9] for inter-study comparisons. Differential gene expression was calculated in studies where there were at least two cell types and three samples for each cell type, using both the within-study normalization data values and the cross-normalization data values. All data was stored in a postgreSQL database (version 9.3). A complete overview of the data processing pipeline is described in Figure 1 .
RESULTS
Molecular database content
We focused on data from the most popular microarray platforms, namely the Affymetrix Human Genome U133 Plus 2.0 Array, the Affymetrix Mouse Genome 430 2.0 Array and the Illumina HumanRef-8 v3.0 Beadchip. The widest variety of tissues and cell types have been profiled on these platforms. Literature searching identified 56 published studies with microarray data from normal cells, kidney disease, pluripotent stem cells (iPS or ESC), or cells derived from the pluripotent stem cells. A summary of samples that were processed is shown in (Table 1) .
Data visualization per study
The microarray processing pipeline generates a number of diagnostic plots for visual inspection, including boxplots of raw and normalized data, principal components analysis plots, and heatmaps of up-and down-regulated genes, if there were sufficient samples and groups to carry out a differential gene analysis. An example of the plots is shown in Figure 2 . In this particular study (GSE9832), it appears from the PCA plot that one of the fibroblast samples (GSM248213) has been wrongly annotated in the GEO record, since its transcriptome profile is more consistent with a pluripotent stem cell.
DISCUSSION
Technological developments have made high-throughput '-omics' analysis increasingly affordable and even routine.
With the wide availability of transcriptome data in public repositories such as Gene Expression Omnibus and ArrayExpress, there is a large body of data to draw upon for meta-analysis. Like CellFinder, contemporary web resources, such as SHOGoiN/CELLPEDIA [10] and Stemformatics [11] , also compile cell-based '-omics' data from public repositories, but only the former associates its data to ontology terms. In this communication, we describe the compilation of transcriptome data from microarrays, with a focus on pluripotent stem cells and engineered or otherwise derived cell types. Once the samples have been annotated to ontology terms by expert curators, each study is processed in a standard way to yield normalized datasets suitable for analysis within one study or across many studies (meta-analysis).
CellFinder's molecular database will be expanded in the future to include a greater number of normal and diseased cell types, as well as transcriptome data from other microarray platforms and RNA-seq studies. Once fully integrated into the CellFinder framework, the database will serve as the data source for CellFinder applications such as MarkerTool and CompareTool, and it will also be possible to query molecular data through ontology terms, for a user-defined analysis. 
